ロード中...
Safety and efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus
Objective: to study the safety and efficacy of the 23-valent polysaccharide pneumococcal vaccine (PPV-23) in patients with systemic lupus erythematosus (SLE).Patients and methods. The study included 75 patients with definite diagnosis of SLE at the age of 19–68 years, 10 (13%) of them had high SLE a...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
IMA-PRESS LLC
2021-06-01
|
| シリーズ: | Современная ревматология |
| 主題: | |
| オンライン･アクセス: | https://mrj.ima-press.net/mrj/article/view/1148 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|